Antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products

  12 March 2021

The objective of the draft reflection paper is to review available information on the emissions and the environmental fate of veterinary medicinal products as sources of antimicrobial resistance (AMR) and antimicrobial resistant genes to and within the environment, and their risk to human and animal health. The document considers the suitability of the current risk assessment process for AMR and risk mitigation recommendations, and notes knowledge gaps and research needs.

Further reading: European Medicines Agency
Author(s): European Medicines Agency
Healthy Animals  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed